Advances in Chronic Kidney Disease
Volume 17, Issue 4 , Pages e17-e26 , July 2010

Health-Related Quality of Life in Hypertension, Chronic Kidney Disease, and Coexistent Chronic Health Conditions

References 

  1. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69–75
  2. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 1989;262:907–913
  3. Bardage C, Isacson DG. Hypertension and health-related quality of life. An epidemiological study in Sweden. J Clin Epidemiol. 2001;54:172–181
  4. Arslantas D, Ayranci U, Unsal A, et al. Prevalence of hypertension among individuals aged 50 years and over and its impact on health related quality of life in a semi-rural area of western Turkey. Chin Med J (Engl). 2008;121:1524–1531
  5. Moum T, Naess S, Sorensen T, et al. Hypertension labelling, life events and psychological well-being. Psychol Med. 1990;20:635–646
  6. Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F, et al. Health-related quality of life of subjects with known and unknown hypertension: Results from the population-based Hortega study. J Hypertens. 2003;21:1283–1289
  7. Cote I, Gregoire JP, Moisan J. Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials. Pharmacoeconomics. 2000;18:435–450
  8. Coyne KS, Davis D, Frech F, et al. Health-related quality of life in patients treated for hypertension: A review of the literature from 1990 to 2000. Clin Ther. 2002;24:142–169
  9. Leppo NE. The first ten years of the World Health Organization. Minn Med. 1958;41:577–583
  10. Dew MA, Switzer GE, DiMartini AF, et al. Psychosocial assessments and outcomes in organ transplantation. Prog Transplant. 2000;10:239–259quiz 260–261
  11. Bulpitt CJ, Fletcher AE. The measurement of quality of life in hypertensive patients: A practical approach. Br J Clin Pharmacol. 1990;30:353–364
  12. Leonetti G, Comerio G, Cuspidi C. Evaluating quality of life in hypertensive patients. J Cardiovasc Pharmacol. 1994;23(suppl 5):S54–S58
  13. Collins AJ, Foley RN, Herzog C, et al. United States Renal Data System 2008 annual data report abstract. Am J Kidney Dis. 2009;53(suppl 1):vi–viiS8–S374
  14. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 suppl 1):S1–S290
  15. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291–1297
  16. Hallan S, Astor B, Romundstad S, et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med. 2007;167:2490–2496
  17. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–1782
  18. McCullough PA, Soman SS, Shah SS, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000;36:679–684
  19. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  20. Kokubo Y, Nakamura S, Okamura T, et al. Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: The Suita Study. Stroke. 2009;40:2674–2679
  21. Wiklund I, Halling K, Ryden-Bergsten T, et al. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. Blood Press. 1997;6:357–364
  22. Degl'Innocenti A, Elmfeldt D, Hofman A, et al. Health-related quality of life during treatment of elderly patients with hypertension: Results from the Study on Cognition and Prognosis in the Elderly (SCOPE). J Hum Hypertens. 2004;18:239–245
  23. Hansson L. The Hypertension Optimal Treatment study and the importance of lowering blood pressure. J Hypertens Suppl. 1999;17:S9–S13
  24. Hayes DK, Denny CH, Keenan NL, et al. Health-related quality of life and hypertension status, awareness, treatment, and control: National Health and Nutrition Examination Survey, 2001–2004. J Hypertens. 2008;26:641–647
  25. Rocco MV, Gassman JJ, Wang SR, et al. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: The Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1997;29:888–896
  26. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005;45:658–666
  27. Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD Patients: Correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4:1293–1301
  28. Finkelstein FO, Wuerth D, Finkelstein SH. Health related quality of life and the CKD patient: Challenges for the nephrology community. Kidney Int. 2009;76:946–952
  29. Weiner DE. Public health consequences of chronic kidney disease. Clin Pharmacol Ther. 2009;86:566–569
  30. Kusek JW, Lee JY, Smith DE, et al. Effect of blood pressure control and antihypertensive drug regimen on quality of life: The African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996;17(suppl 4):40S–46S
  31. Wright JT, Kusek JW, Toto RD, et al. Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996;17(suppl 4):3S–16S
  32. Kusek JW, Greene P, Wang SR, et al. Cross-sectional study of health-related quality of life in African Americans with chronic renal insufficiency: The African American Study of Kidney Disease and Hypertension Trial. Am J Kidney Dis. 2002;39:513–524
  33. Lash JP, Wang X, Greene T, et al. Quality of life in the African American Study of Kidney Disease and Hypertension: Effects of blood pressure management. Am J Kidney Dis. 2006;47:956–964
  34. The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group. Arch Intern Med. 1991;151:1413–1423
  35. De Rosa ML, Cardace P, Rossi M, et al. Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients. J Hum Hypertens. 2002;16:133–140
  36. Ruggenenti P, Perna A, Gherardi G, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999;354:359–364
  37. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA. 2001;285:2719–2728
  38. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet. 1997;349:1857–1863
  39. Ruggenenti P, Perna A, Remuzzi G. ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop: A post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol. 2001;12:2832–2837
  40. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med. 1996;334:939–945
  41. Chiurchiu C, Remuzzi G, Ruggenenti P. Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: The data of the meta-analyses. J Am Soc Nephrol. 2005;16(suppl 1):S58–S63
  42. Swenson JR, Clinch JJ. Assessment of quality of life in patients with cardiac disease: The role of psychosomatic medicine. J Psychosom Res. 2000;48:405–415
  43. Li C, Ford ES, Mokdad AH, et al. Clustering of cardiovascular disease risk factors and health-related quality of life among US adults. Value Health. 2008;11:689–699
  44. Bayliss EA, Bayliss MS, Ware JE, et al. Predicting declines in physical function in persons with multiple chronic medical conditions: What we can learn from the medical problem list. Health Qual Life Outcomes. 2004;2:47
  45. Kalantar-Zadeh K, Unruh M. Health related quality of life in patients with chronic kidney disease. Int Urol Nephrol. 2005;37:367–378
  46. Aydemir O, Ozdemir C, Koroglu E. The impact of co-morbid conditions on the SF-36: A primary-care-based study among hypertensives. Arch Med Res. 2005;36:136–141
  47. Johansen KL, Kutner NG, Young B, et al. Association of body size with health status in patients beginning dialysis. Am J Clin Nutr. 2006;83:543–549
  48. Souza EN, Quadros AS, Maestri R, et al. Predictors of quality of life change after an acute coronary event. Arq Bras Cardiol. 2008;91:229–235252–259
  49. Kapetanakis EI, Stamou SC, Petro KR, et al. Comparison of the quality of life after conventional versus off-pump coronary artery bypass surgery. J Card Surg. 2008;23:120–125
  50. Herlitz J, Caidahl K, Wiklund I, et al. Impact of a history of hypertension on symptoms and quality of life prior to and at five years after coronary artery bypass grafting. Blood Press. 2000;9:52–63
  51. Agewall S, Wikstrand J, Dahlof C, et al. Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk. Am J Hypertens. 1996;9:545–550
  52. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053
  53. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999;15:205–218
  54. Wee HL, Cheung YB, Li SC, et al. The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: Is the whole greater than the sum of its parts?. Health Qual Life Outcomes. 2005;3:2
  55. Miksch A, Hermann K, Rolz A, et al. Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany—A cross-sectional survey. Health Qual Life Outcomes. 2009;7:19
  56. Papadopoulos AA, Kontodimopoulos N, Frydas A, et al. Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health. 2007;7:186
  57. Lloyd A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health. 2001;4:392–400
  58. Wexler DJ, Grant RW, Wittenberg E, et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006;49:1489–1497
  59. Hart HE, Redekop WK, Berg M, et al. Factors that predicted change in health-related quality of life were identified in a cohort of diabetes mellitus type 1 patients. J Clin Epidemiol. 2005;58:1158–1164
  60. Mena Martin FJ, Martin Escudero JC, Simal Blanco F, et al. Type 2 diabetes mellitus and health-related quality of life: Results from the Hortega Study [in Spanish]. An Med Interna. 2006;23:357–360
  61. Bounthavong M, Law AV. Identifying health-related quality of life (HRQL) domains for multiple chronic conditions (diabetes, hypertension and dyslipidemia): Patient and provider perspectives. J Eval Clin Pract. 2008;14:1002–1011
  62. Ostman J, Asplund K, Bystedt T, et al. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group. J Intern Med. 1998;244:95–107
  63. McGill JB, Bakris GL, Fonseca V, et al. Beta-blocker use and diabetes symptom score: Results from the GEMINI study. Diabetes Obes Metab. 2007;9:408–417
  64. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care. 1999;22:1125–1136
  65. Zahran HS, Kobau R, Moriarty DG, et al. Health-related quality of life surveillance—United States, 1993-2002. MMWR Surveill Summ. 2005;54:1–35
  66. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818–827
  67. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255–3264
  68. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898
  69. Fogari R, Zoppi A. Effect of antihypertensive agents on quality of life in the elderly. Drugs Aging. 2004;21:377–393
  70. Applegate WB, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med. 1994;154:2154–2160
  71. Degl'Innocenti A, Elmfeldt D, Hansson L, et al. Cognitive function and health-related quality of life in elderly patients with hypertension—Baseline data from the study on cognition and prognosis in the elderly (SCOPE). Blood Press. 2002;11:157–165
  72. Robbins MA, Elias MF, Croog SH, et al. Unmedicated blood pressure levels and quality of life in elderly hypertensive women. Psychosom Med. 1994;56:251–259
  73. Fletcher AE, Bulpitt CJ, Thijs L, et al. Quality of life on randomized treatment for isolated systolic hypertension: Results from the Syst-Eur Trial. J Hypertens. 2002;20:2069–2079
  74. Applegate WB, Phillips HL, Schnaper H, et al. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med. 1991;151:1817–1823
  75. Benetos A, Consoli S, Safavian A, et al. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension. Am Heart J. 2000;140:E11
  76. Bulpitt CJ, Connor M, Schulte M, et al. Bisoprolol and nifedipine retard in elderly hypertensive patients: Effect on quality of life. J Hum Hypertens. 2000;14:205–212
  77. Martin CK, Church TS, Thompson AM, et al. Exercise dose and quality of life: A randomized controlled trial. Arch Intern Med. 2009;169:269–278

 This work was supported by NIH DK66006 and DK77785 (Unruh). Dr. Unruh also receives grant support from the Paul Teschan Research Fund, Norman Coplon Research Award, and the Baxter Extramural Grant Program. Dr. Unruh serves on the Medical Advisory Board for Baxter Healthcare.

PII: S1548-5595(10)00067-4

doi: 10.1053/j.ackd.2010.04.002

Advances in Chronic Kidney Disease
Volume 17, Issue 4 , Pages e17-e26 , July 2010

Article Tools

* Image Usage & Resolution